References
- Chinese Pharmacopoeia Commission. (2015), Chinese Pharmacopoeia (PartIV). Beijing, China: China Medical Science and Technology Press. 356–362.
- Doi H, Sato K, Shindou H, et al. (2016). Blood-brain barrier permeability of ginkgolide: Comparison of the behavior of PET probes 7alpha-[(18)F]fluoro- and 10-O-p-[(11)C]methylbenzyl ginkgolide B in monkey and rat brains. Bioorg Med Chem 24:5148–57.
- Food and Drug Administration. 2018. Guidance for industry bioanalytical method validation [online]. Food and Drug Administration. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm070107.pdf [Accessed 24 May 2018]
- Hui AL, Wu ZY, Yuan Y, et al. (2013). Progress in synthesis and antagonistic activities towards PAFR and GlyR of ginkgolide derivatives and analogs. Chin J Org Chem 33:1263–72.
- Islam MT, da Silva CB, de Alencar MV, et al. (2016). Diterpenes: advances in neurobiological drug research. Phytother Res 30:915–28.
- Li XJ, Wang YQ, Yang J, et al. (2015). Semi-quantitative determination of monocarboxylate forms of ginkgolide B in plasma by UPLC-MS. Anal Bioanal Chem 407:4121–9.
- Liu XW, Yang JL, Niu W, et al. (2018). Human pharmacokinetics of ginkgo terpene lactones and impact of carboxylation in blood on their platelet-activating factor antagonistic activity. Acta Pharmacol Sin 39:1935–46.
- Lu YM, Pan J, Zhang WN, et al. (2015). Synthesis, in silico and in vivo blood brain barrier permeability of ginkgolide B cinnamate. Fitoterapia 106:110–4.
- Qiu Z, Wang L, Dai Y, et al. (2015). The potential drug-drug interactions of ginkgolide B mediated by renal transporters. Phytother Res 29:662–7.
- Shao F, Zhang H, Xie L, et al. (2017). Pharmacokinetics of ginkgolides A, B and K after single and multiple intravenous infusions and their interactions with midazolam in healthy Chinese male subjects. Eur J Clin Pharmacol 73:537–46.
- van Beek TA. (2005). Ginkgolides and bilobalide: their physical, chromatographic and spectroscopic properties. Bioorg Med Chem 13:5001–12.
- Wang S, Ouyang B, Aa J, et al. (2016). Pharmacokinetics and tissue distribution of ginkgolide A, ginkgolide B, and ginkgolide K after intravenous infusion of ginkgo diterpene lactones in a rat model. J Pharm Biomed Anal 126:109–16.
- Wang DL, Peng DY, Tao XH, et al. (2013). The pharmacokinetics and conversion of the lactone to the carboxylate forms of ginkgolide B in rat plasma. J Asian Nat Prod Res 15:337–43.
- Yuan Y, Pan J, Wu Z, et al. (2013). Validated LC-MS-MS method for the determination of prodrug of ginkgolide B in rat plasma and brain: application to pharmacokinetic study. J Chromatogr Sci 51:266–72.
- Yuan Q, Wang CW, Shi J, Lin ZX. (2017). Effects of Ginkgo biloba on dementia: an overview of systematic reviews. J Ethnopharmacol 195:1–9.
- Zhang HY, Qi Y, Liao YH, et al. (2011). Study on safety and solubilization of solubilizing excipients used in injections. Chin J Exp Trad Med Formulae 17:1–4.
- Zhao J, Geng T, Wang Q, et al. (2015). Pharmacokinetics of ginkgolide B after oral administration of three different ginkgolide B formulations in Beagle dogs. Molecules 20:20031–41.